MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Terns Pharmaceuticals, Inc. Common Stock

TERN

#1280
Terns Pharmaceuticals, Inc. Common Stock
42.12
+6.10%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
42.12
42.12
Intervallo Annuale
1.86
48.26
Variazione giornaliera
+6.10%
Variazione Mensile
+20.62%
Variazione di 6 mesi
+507.79%
Variazione Annuale
+1076.54%
Chiusura Precedente
39.70
Open
42.12
Bid
Ask
Low
42.12
High
42.12
Volume
159
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. TERN
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value 2021202220232024 TTM

Notizie

Zacks Zacks
AMRX CSTL VTRS TERN
2026.02.23
Viatris Stock to Report Q4 Earnings: What's in the Cards?
Investing Investing
TERN
2026.02.09
Leerink Partners avvia copertura su Terns Pharmaceuticals con rating Outperform
Investing Investing
TERN
2026.02.09
Leerink Partners initiates Terns Pharmaceuticals stock with Outperform rating
Zacks Zacks
TERN
2026.02.04
Wall Street Analysts See a 50.91% Upside in Terns Pharmaceuticals (TERN): Can the Stock Really Move This High?
Investing Investing
CYTK MDGL PTGX SRRK TERN
2026.02.03
I migliori titoli biotech da tenere d’occhio nel 2026, secondo Truist
Investing Investing
CYTK MDGL PTGX SRRK TERN
2026.02.03
Top Biotech Stocks to Watch in 2026, According to Truist
Investing Investing
TVTX ZYME MIRM TERN ABVX
2026.01.23
HBM Healthcare: utile di 9 mesi raggiunge 286 milioni di CHF con NAV in crescita del 18%
Investing Investing
TVTX ZYME TERN ABVX
2026.01.23
Swiss HBM Healthcare nine-month profit hits CHF 286 mln as NAV jumps 18%
Investing Investing
ELVN TERN
2026.01.22
Lyssikatos, CSO di Enliven Therapeutics, vende azioni ELVN per 535.000$
Investing Investing
ELVN TERN
2026.01.22
Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock
Investing Investing
TERN
2026.01.22
Terns Pharmaceuticals modifica l’accordo di licenza con Hansoh per i diritti di TERN-701
Investing Investing
TERN
2026.01.22
Terns Pharmaceuticals amends license agreement with Hansoh for TERN-701 rights

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd